These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Age as a predictor of treatment response in endogenous depression. Brown RP; Sweeney J; Frances A; Kocsis JH; Loutsch E J Clin Psychopharmacol; 1983 Jun; 3(3):176-8. PubMed ID: 6875025 [No Abstract] [Full Text] [Related]
24. [Toxic tricyclic drug plasma level caused by fluoxetine]. Hambrecht M Psychiatr Prax; 1995 Nov; 22(6):252-3. PubMed ID: 8570758 [TBL] [Abstract][Full Text] [Related]
25. Do depressed subjects who have failed both fluoxetine and a tricyclic antidepressant respond to the combination? Levitt AJ; Joffe RT; Kamil R; McIntyre R J Clin Psychiatry; 1999 Sep; 60(9):613-6. PubMed ID: 10520980 [TBL] [Abstract][Full Text] [Related]
27. Fluoxetine (prozac) in depresion of adults. Kocur J; Rydzynski Z; Duszyk S; Gruszczynski W; Trendak W Homeost Health Dis; 1991; 33(5-6):295. PubMed ID: 18265505 [No Abstract] [Full Text] [Related]
28. A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Nelson JC; Mazure CM; Bowers MB; Jatlow PI Arch Gen Psychiatry; 1991 Apr; 48(4):303-7. PubMed ID: 2009031 [TBL] [Abstract][Full Text] [Related]
29. Lack of advantage for imipramine combined with lithium versus imipramine alone in the treatment of major depression--a double-blind controlled study. Shahal B; Piel E; Mecz L; Kremer I; Klein E Biol Psychiatry; 1996 Dec; 40(11):1181-3. PubMed ID: 8931923 [No Abstract] [Full Text] [Related]
30. Lithium and desipramine versus desipramine alone in the treatment of severe major depression: a preliminary study. Cappiello A; McDougle CJ; Delgado PL; Malison RT; Jatlow P; Charney DS; Heninger GR; Price LH Int Clin Psychopharmacol; 1998 Sep; 13(5):191-8. PubMed ID: 9817623 [TBL] [Abstract][Full Text] [Related]
32. Relapse of depression during continuation treatment: three clinical vignettes. Nasr SJ; Gaviria M; Grupp M; Rodgers P J Clin Psychopharmacol; 1983 Feb; 3(1):32-4. PubMed ID: 6833521 [No Abstract] [Full Text] [Related]
33. Toxicity resulting from lithium augmentation of antidepressant treatment in elderly patients. Austin LS; Arana GW; Melvin JA J Clin Psychiatry; 1990 Aug; 51(8):344-5. PubMed ID: 2380160 [TBL] [Abstract][Full Text] [Related]
34. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients. Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression. Rothschild AJ; Samson JA; Bessette MP; Carter-Campbell JT J Clin Psychiatry; 1993 Sep; 54(9):338-42. PubMed ID: 8104930 [TBL] [Abstract][Full Text] [Related]
36. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients. Diaz A; Fouilloux C; Ortiz S Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564 [No Abstract] [Full Text] [Related]